Compelling indications should be listed for individual beta-blockers (due to diversity), not for the whole class.
Conclusions BBs differ within the class in so many ways that it is not only logical but also practical for real-life clinical practice that experts in the field make a list of the compelling indications for individual BBs. Time has come to incorporate our knowledge about BBs into a new approach of presenting these useful and very individual drugs.
PMID: 32418526 [PubMed - as supplied by publisher]
Source: Current Vascular Pharmacology - Category: Drugs & Pharmacology Authors: Koracevic G, Micic S, Stojanovic M, Lovic D, Simic D, Colic M, Koracevic M, Stojkovic A, Paunovic M Tags: Curr Vasc Pharmacol Source Type: research
More News: Aortic Aneurysm | Arrhythmia | Beta-Blockers | Bisoprolol | Cardiology | Cardiomyopathy | Cholesterol | Clinical Trials | Congestive Heart Failure | Coreg | Drugs & Pharmacology | Emergency Medicine | General Medicine | Heart | Heart Attack | Heart Failure | Hypertension | Hypertrophic Cardiomyopathy | Inderal | Marfan Syndrome | Men | Toprol | Ventricular Tachycardia